Cyclerion Therapeutics, Inc. (CYCN)
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
Address
301 BINNEY STREET
CAMBRIDGE, MA 02142
Founded
2018
Number of Employees
1
Website
http://www.cyclerion.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)